COVID-19 Antibodies Among Healthcare Workers
Completed
- Conditions
- SARS-CoV 2COVID-19
- Interventions
- Diagnostic Test: COVID-19 IgG/IgM Rapid Test Cassette test (Healgen Scientific, Houston, Texas, USA)
- Registration Number
- NCT04425889
- Lead Sponsor
- Hospital Universitario Dr. Jose E. Gonzalez
- Brief Summary
Observational, point of prevalence study determining the presence of anti-SARS-CoV-2 antibody
- Detailed Description
All Healthcare workers (HCW) who had entered contaminated areas at least once and that 14 days or more had passed from their first entrance to contaminated areas were included. They were classified as asymptomatic and pauci-symptomatic. A COVID-19 IgG/IgM rapid test was used for antibody detection, and selected participants were subject to real time polymerase chain reaction (qPCR) for SARS-CoV-2.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 156
Inclusion Criteria
- All healthcare workers who had entered contaminated areas at least once and that 14 days or more had passed from their first entrance were included
Exclusion Criteria
- Healthcare workers who did not have exposure for more or equal 14 days
- Healthcare workers who did not wish to participate
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description exposed Healthcare workers COVID-19 IgG/IgM Rapid Test Cassette test (Healgen Scientific, Houston, Texas, USA) Healthcare workers working for 8 weeks in a COVID-19 area
- Primary Outcome Measures
Name Time Method Presence of antibody through study completion, an average of 8 weeks presence of IgG and/or IgM against SARS-CoV-2
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Hospital Universitario José E. Gonzalez
🇲🇽Monterrey, Nuevo Leon, Mexico